India to United Arab Emirates: Amphotericin Export Trade Route
India has recorded 57 verified shipments of Amphotericin exported to United Arab Emirates, representing a combined trade value of $2.5M USD. This corridor is served by 17 active Indian exporters, with an average shipment value of $43.9K USD. The leading Indian exporter is BHARAT SERUMS AND VACCINES LIMITED, which accounts for 92% of total export value with 9 shipments worth $2.3M USD. On the buying side, MEDIST FZE is the largest importer in United Arab Emirates with $1.8M USD in purchases. The top 3 suppliers — BHARAT SERUMS AND VACCINES LIMITED, EMCURE PHARMACEUTICALS LIMITED, RMPL PHARMA LLP — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United Arab Emirates Amphotericin corridor is one of India's established pharmaceutical export routes, with 57 shipments documented worth a combined $2.5M USD. The route is dominated by BHARAT SERUMS AND VACCINES LIMITED, which alone accounts for roughly 92% of all export value, reflecting the consolidated nature of India's amphotericin manufacturing sector.
Across 17 active suppliers, the average shipment value stands at $43.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with amphotericin's non-urgent bulk-order profile.
Shipment activity peaks during UNAVAILABLE, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 23.42%, placing it at rank #1 among India's top amphotericin export destinations globally.
On the import side, key buyers of Indian amphotericin in United Arab Emirates include MEDIST FZE, TRANZONE FZE., TRANZONE FZE and 19 others. MEDIST FZE is the single largest importer with 7 shipments valued at $1.8M USD.
